A single test that can give false reassurance sounds bad. But a $10 test for the coronavirus, if repeated daily, would discover real infections, say proponents of such tests as screening tools.
"State, local and tribal governments are uniquely positioned to determine the level of mitigation required to combat the virus in their communities," the African American Mayors Association urges.
Early data suggest the pandemic may be driving up overdoses. Author Barbara Andraka-Christou says the solution to the addiction crisis is right before us: Improve access to life-saving medication.
Researchers believe gene therapy is poised to change the lives of thousands with the fatal genetic disorder Duchenne muscular dystrophy — thanks to over 40 years of scientist Jude Samulski's work.
The first gene therapy for hemophilia could be approved by the FDA within six months, according to the drugmaker, raising hopes among families. But the drug's price could be $3 million per patient.
The U.S. health care industry has begun reducing the use of high-risk opioid pain medications. But clinicians in many fields still prescribe large quantities of opioids, ignoring federal guidelines.
Companies that made hats, socks and teddy bears have started producing surgical masks to protect people from COVID-19. Some sellers exaggerate their standing with the Food and Drug Administration.
Dr. Christine Montross says people with serious mental illnesses in the U.S. are far more likely to be incarcerated than to be treated in a psychiatric hospital. Her new book is Waiting for an Echo.
When scientists revved up the production of an enzyme called GPLD1 in older mice, it stimulated nerve growth in their brains and the animals navigated a maze better.
Dentists spend their careers eye to eye with infectious patients, their hands inside gaping mouths, and have a vested interest in making sure everyone stays safe. Here's how they do it.
Structures inside healthy brain cells nimbly move from one state to the next to perform different functions. But in certain degenerative brain diseases, scientists now think, that process gets stuck.
The federal government on Tuesday announced grants for the development and manufacture of vaccines and treatments for COVID-19 totaling over $2 billion.
J. Paul Taylor has found that some brain diseases, like Alzheimer's and ALS, are linked to a basic process inside brain cells. Scientists hope drugs that tweak the process can treat illnesses.
The federal government has waived a law that required an in-person doctor's visit before patients could be prescribed drugs that quell withdrawal symptoms. That's a boon for patients, counselors say.